Safety and efficacy of 24 weeks of pemvidutide in metabolic dysfunction-associated steatotic liver disease: A randomized, controlled clinical trial

20255 citationsJournal Articlegold Open Access

Authors

The study is registered at ClinicalTrials.gov (NCT05292911).

Good health and well-being

Published in: JHEP Reports

Volume 7, Issue 11, pp. 101483-101483

Field-Weighted Citation Impact: 6.90